Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Apr;2(2):otaa026.
doi: 10.1093/crocol/otaa026. Epub 2020 Apr 16.

The Risk of SARS-CoV-2 in Immunosuppressed IBD Patients

Affiliations
Free PMC article

The Risk of SARS-CoV-2 in Immunosuppressed IBD Patients

Peter D R Higgins et al. Crohns Colitis 360. .
Free PMC article

Abstract

This is a rapid review of the risk of infection with SARS-CoV-2, the risk of symptomatic cases of COVID-19, and the severity of these cases in IBD patients. Guidance on how to manage IBD patients at risk for infection, and IBD patients after infection is provided. The prevention of infection in both patients and health care providers by reducing elective visits and procedures, utilizing telemedicine, and social isolation is also emphasized to maintain health care services for IBD patients during a growing pandemic.

Similar articles

See all similar articles

LinkOut - more resources

Feedback